1. Prosonix Announce Agreement With Trimel Biopharma
(News/Latest)

...  Prosonix' proprietary particle engineering technologies deliver unique, crystalline, excipient free, highly performing, stable drug particles that offer significant and distinct and quantifiable advantages ...

2. Prosonix Announce Agreement With Trimel Biopharma
(News/Newsflash)

...  Prosonix' proprietary particle engineering technologies deliver unique, crystalline, excipient free, highly performing, stable drug particles that offer significant and distinct and quantifiable advantages ...

3. Ultrasound in Crystallization
(Blog/blog)

I would be interested to hear about perceptions of ultrasound in crystallization  whether for standard batch crystallization or indeed continuous processing. What are you experiences and opinions?  Have ...

4. Large scale co-crystal approaches
(Blog/blog)

Of course quite often some co-crystals are very easy to deal with and simple cooling crystallization can be straightforward - they simply fall out of solution -but more often than not they can be awkward ...

5. co-crystal formation.
(Blog/blog)

The scientific fraternity is still uncertain whether we really need a liquid assisted grinding or solvent recrystallization for co-crystal synthesis. There are interesting instances where one or the other ...

6. Scale-up of co-crystals
(Blog/blog)

There appears to be a number of people looking into ways to up-scale co-crystals (from the bench) by conventional batch crystallisation. Having had discussions on continuous crystallisation as an alternative ...

7. production of fine chemicals and pharmaceuticals
(Blog/blog)

Can ultrasound be used for continuous crystallisation manufacturing techniques ensure consistent crystal properties (size, distribution and morphology) and better filtration rates in the production of ...

8. Prosonix Announce The Scale-Up Of UMAX technology
(News/Latest)

... proprietary UMAX® technology delivers unique, crystalline, excipient free, highly performing, stable drug particles, that offer significant and distinct and quantifiable advantages over current industry ...

9. Prosonix Announce The Scale-Up Of UMAX technology
(News/Newsflash)

... UMAX® technology delivers unique, crystalline, excipient free, highly performing, stable drug particles, that offer significant and distinct and quantifiable advantages over current industry practice, ...

10. November 3-4, 2010: Crystallization & Polymorphism, Florida
(events/events)

Prosonix CTO Dr Graham Ruecroft will be presenting and chairing a seesion at the 9th International Conference and Exhibition on Polymorphism & Crystallization organised by Scientific Update, UK, taking ...

11. Prosonix Announce The Launch Of UMAX technology
(News/Latest)

Prosonix is pleased to announce the launch of its UMAX® technology - an acronym for Ultrasound Mediated Amorphous to Crystalline transition - which is a new disruptive particle engineering technology set ...

12. Prosonix Announce The Launch Of UMAX technology
(News/Newsflash)

Prosonix is pleased to announce the launch of its UMAX® technology - an acronym for Ultrasound Mediated Amorphous to Crystalline transition - which is a new disruptive particle engineering technology set ...

13. UMAX Pharmaceutical Particle Engineering
(technology/Technology)

The Prosonix power ultrasound assisted particle engineering technology UMAX®, (Ultrasound Mediated Amorphous to Crystalline transition) can be used for the manufacture of optimal particles designed and ...

14. Prosonix CEO David Hipkiss talks to CHEManager
(News/Latest)

David Hipkiss, CEO of Prosonix, recently spoke to CHEM-anager Europe about the company's endeavours in using its proprietary sonocrystallization and particle engineering technologies for Making Better ...

15. Prosonix Attains International Quality Approval
(News/Latest)

... external auditors SGS (UK) Ltd.   This covers Prosonix full range of activities from the Research and Development of ultrasonic particle engineering solutions for crystallisation and formulation ...

16. Prosonitron
(slider/slider)

Prosonix provide cGMP & ATEX sonocrystallization Prosonitron™ ultrasonic process and reactor technology. They are aligned with emergent FDA “QbD” and “Design for Intent” philosophy. Our proprietary systems ...

17. SonoLab
(slider/slider)

Multipurpose laboratory equipment for sonocrystallization & sonochemistry are now available. These highly effective and flexible research tools facilitate 100ml – 100L operational capability in batch or ...

18. Ultrasound
(slider/slider)

Power ultrasound facilitates controlled and reproducible crystal nucleation which is fundamental in controlling crystallization. Sonocrystallization delivers controlled nucleation and superior control ...

19. Particles
(slider/slider)

ProsonitronTM, DISCUS®, SAXTM,  UMAX® SAXTM  and PRT based process technologies are proprietary "Solution-to-Particle" methods for controlling crystal size, shape and polymorph for APIs and helping ...

20. KTP Research Funding For Prosonix and Bath University
(News/Latest)

... to develop methodology and identify new processing technology for the manufacture of pharmaceutical co-crystals and binary API crystals suitable for use in inhaled and oral medicines.  The primary ...